Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU

BURLINGTON, N.C., July 29, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union's (EU) new In Vitro Diagnostic Regulation (IVDR). It is now the first and only test of its kind in the EU CE-marked for comprehensive solid tumor profiling. This marks a significant milestone in expanding access to personalized treatment options for the approximately 2.7 million people diagnosed with cancer every year in the EU.

Read more at prnewswire.com